vs
Side-by-side financial comparison of Anteris Technologies Global Corp. (AVR) and ENvue Medical, Inc. (FEED). Click either name above to swap in a different company.
ENvue Medical, Inc. is the larger business by last-quarter revenue ($312.0K vs $310.0K, roughly 1.0× Anteris Technologies Global Corp.). ENvue Medical, Inc. runs the higher net margin — -3919.6% vs -9420.0%, a 5500.4% gap on every dollar of revenue. ENvue Medical, Inc. produced more free cash flow last quarter ($-2.7M vs $-18.9M).
Anteris Technologies Global Corp is a medical technology firm specializing in innovative structural heart care solutions. It develops and commercializes bioprosthetic heart valves and transcatheter intervention products, serving healthcare providers across North America, Europe, and Asia-Pacific, with core focus on cardiac surgery and interventional cardiology segments.
ENvue Medical, Inc. is a medical technology firm specializing in advanced enteral feeding systems and related clinical support solutions. It serves healthcare providers, hospitals and long-term care facilities across North America, focusing on improving safety and efficiency of care for patients requiring enteral nutrition support.
AVR vs FEED — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $310.0K | $312.0K |
| Net Profit | $-29.2M | $-12.2M |
| Gross Margin | 70.6% | -118.6% |
| Operating Margin | -9343.5% | -4748.1% |
| Net Margin | -9420.0% | -3919.6% |
| Revenue YoY | — | -29.7% |
| Net Profit YoY | — | -754.6% |
| EPS (diluted) | $-0.74 | $-28.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $310.0K | $312.0K | ||
| Q3 25 | $429.0K | $722.0K | ||
| Q2 25 | $618.0K | $494.0K | ||
| Q1 25 | $556.0K | $1.0M | ||
| Q4 24 | — | $444.0K | ||
| Q3 24 | — | $376.0K | ||
| Q2 24 | — | $817.0K | ||
| Q1 24 | — | $921.0K |
| Q4 25 | $-29.2M | $-12.2M | ||
| Q3 25 | $-22.2M | $510.0K | ||
| Q2 25 | $-20.8M | $-4.0M | ||
| Q1 25 | $-21.9M | $-2.5M | ||
| Q4 24 | — | $-1.4M | ||
| Q3 24 | — | $-998.0K | ||
| Q2 24 | — | $-688.0K | ||
| Q1 24 | — | $-588.0K |
| Q4 25 | 70.6% | -118.6% | ||
| Q3 25 | 71.3% | 26.2% | ||
| Q2 25 | 76.1% | -7.1% | ||
| Q1 25 | 62.8% | 36.0% | ||
| Q4 24 | — | 63.7% | ||
| Q3 24 | — | 35.4% | ||
| Q2 24 | — | 52.4% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -9343.5% | -4748.1% | ||
| Q3 25 | -5190.0% | -311.2% | ||
| Q2 25 | -3379.3% | -804.9% | ||
| Q1 25 | -3917.3% | -180.7% | ||
| Q4 24 | — | -308.6% | ||
| Q3 24 | — | -258.0% | ||
| Q2 24 | — | -82.5% | ||
| Q1 24 | — | -61.7% |
| Q4 25 | -9420.0% | -3919.6% | ||
| Q3 25 | -5185.1% | 70.6% | ||
| Q2 25 | -3371.2% | -803.8% | ||
| Q1 25 | -3932.4% | -243.4% | ||
| Q4 24 | — | -322.3% | ||
| Q3 24 | — | -265.4% | ||
| Q2 24 | — | -84.2% | ||
| Q1 24 | — | -63.8% |
| Q4 25 | $-0.74 | $-28.73 | ||
| Q3 25 | $-0.62 | $-0.91 | ||
| Q2 25 | $-0.58 | $-1.03 | ||
| Q1 25 | $-0.61 | $3.98 | ||
| Q4 24 | — | $-108.94 | ||
| Q3 24 | — | $-3.56 | ||
| Q2 24 | — | $-27.18 | ||
| Q1 24 | — | $2.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.2M |
| Total DebtLower is stronger | $22.0K | — |
| Stockholders' EquityBook value | $-93.0K | $33.5M |
| Total Assets | $23.0M | $41.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.2M | ||
| Q3 25 | — | $7.0M | ||
| Q2 25 | — | $4.0M | ||
| Q1 25 | $49.0M | — | ||
| Q4 24 | — | $752.0K | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $22.0K | — | ||
| Q3 25 | $26.0K | — | ||
| Q2 25 | $30.0K | — | ||
| Q1 25 | $30.0K | $1.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-93.0K | $33.5M | ||
| Q3 25 | $3.7M | $42.5M | ||
| Q2 25 | $24.4M | $40.5M | ||
| Q1 25 | $43.3M | $35.7M | ||
| Q4 24 | — | $627.0K | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | $23.0M | $41.1M | ||
| Q3 25 | $19.1M | $54.4M | ||
| Q2 25 | $39.9M | $51.5M | ||
| Q1 25 | $58.8M | $44.1M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | — | $5.7M | ||
| Q1 24 | — | $6.2M |
| Q4 25 | — | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | 0.04× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.5M | $-2.7M |
| Free Cash FlowOCF − Capex | $-18.9M | $-2.7M |
| FCF MarginFCF / Revenue | -6104.5% | -865.1% |
| Capex IntensityCapex / Revenue | 128.1% | 7.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-79.8M | $-9.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.5M | $-2.7M | ||
| Q3 25 | $-18.3M | $-2.0M | ||
| Q2 25 | $-19.5M | $-3.4M | ||
| Q1 25 | $-21.5M | $-1.3M | ||
| Q4 24 | — | $-548.0K | ||
| Q3 24 | — | $-836.0K | ||
| Q2 24 | — | $-553.0K | ||
| Q1 24 | — | $-579.0K |
| Q4 25 | $-18.9M | $-2.7M | ||
| Q3 25 | $-19.0M | $-2.0M | ||
| Q2 25 | $-20.1M | $-3.4M | ||
| Q1 25 | $-21.7M | $-1.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-555.0K | ||
| Q1 24 | — | $-580.0K |
| Q4 25 | -6104.5% | -865.1% | ||
| Q3 25 | -4434.5% | -276.7% | ||
| Q2 25 | -3247.9% | -685.6% | ||
| Q1 25 | -3909.5% | -131.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -67.9% | ||
| Q1 24 | — | -63.0% |
| Q4 25 | 128.1% | 7.4% | ||
| Q3 25 | 180.0% | 3.9% | ||
| Q2 25 | 86.9% | 0.8% | ||
| Q1 25 | 44.6% | 0.5% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | -3.86× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
